Bangladesh to inoculate 12cr doses of vaccine by next January

Minister of Health and Family Welfare Zahid Maleque stated today that the country aims to vaccinate 12 doses of vaccine by January 2022, as the government ramped up efforts to collect the requisite number of COVID-19 vaccines.

“We have already delivered 70 million doses of COVID-19 vaccine… by January next year, we will be able to vaccinate 12 crore doses of vaccine,” he stated at the DBL Pharmaceuticals Ltd’s inauguration celebration in Kashimpur, Gazipur, according to an official release.

Dr. Md Habibe Millat, MP, Major General Mahabubur Rahman, Director General of the Directorate General of Drug Administration (DGDA), and Abdul Wahed, Chairman of DBL Pharmaceuticals Ltd, were among those who spoke at the event.

COVID-19 vaccines would be delivered to all citizens of Bangladesh, according to Prime Minister Sheikh Hasina’s direction, according to the health minister, who added that the government had purchased 21 crore doses of COVID-19 vaccines.

“This month, Bangladesh will receive three crore doses, and we hope to receive the requisite quantity of coronavirus vaccines in phases,” he added.

“Bangladesh’s success in controlling coronavirus has been acclaimed around the world,” he added.

Maleque stated that there is no shortage of medicinal products in the country during the COVID-19 outbreak. After addressing domestic demand, Bangladesh pharmaceutical companies earned a large amount of foreign currency by exporting pharmaceutical items to various nations, he noted.

According to health ministry sources, Bangladesh established a goal of vaccinating 80 percent of the country’s population by 2022 as part of an expedited inoculation campaign, anticipating receipt of essential COVID-19 vaccines within the predicted schedule.

To combat the dangerous disease, Bangladesh has licensed eight COVID-19 vaccinations so far.

Moderna, Johnson & Johnson, CoronaVac, Pfizer, Covishield, Sputnik V, AstraZeneca, and Sinopharm are among the COVID-19 vaccines that have been approved.

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments